In preventive experiments of heart failure with reduced ejection fraction (HFrEF) due to experimental autoimmune myocarditis (EAM), 3 weeks of treatment with an ARB was started simultaneously with myosin immunization. The gene discussed is MYH14; the disease is heart failure.